Persons Reported to be living with HIV infection and with AIDS reported
Year Adults/Adolescents Children Under 13 Years old Total Cumulative Totals
  HIV AIDS HIV AIDS HIV AIDS Adults / Adolescents Children Under 13 Years old Total
2000 Confidential 4,083 Confidential 11 Confidential 4,094 4,083 11 4,094
2001

Confidential

4,281

 Confidential 11 Confidential 4,281 4,281 11 4,292
2002 Confidential 4,881 Confidential 7 Confidential 4,889 4,881 7 4,889
                   

 

 

HIV Infection Cases  from areas with confidential HIV infection reporting
Year   Cumulative Totals
    Adults / Adolescents Children Under 13 Years old Total
2000 Confidential Confidential Confidential Confidential
2001 Confidential Confidential Confidential Confidential
2002 Confidential Confidential Confidential Confidential
         

 

Adult/Adolescent HIV infection and AIDS cases reported in the United States
Year Males Females
  HIV AIDS HIV AIDS
2000 Confidential 434 Confidential 79
2001 Confidential 440 Confidential 72
         

 

New Pediatric AIDS cases reported

Year
2000 2
2001 1

 

AIDS cases and annual rates per 100,000 population by Metropolitan area reported through June 2000

 

 1999

2000

 Through June 2001

Cumulative Totals
City No No. No. Adults / Adolescents Children under 13 Years old Total

Seattle

 240 301 335 6,835 20 6,855
Tacoma 49 58 64 863 9 872

 

 

Cumulative AIDS Cases

Cumulative Number of AIDS Cases, Reported through 2002 10,473
Cumulative Number of Adult/Adolescent AIDS Cases, Reported through 2002 10,439
Cumulative Number of AIDS Cases in Children <13, Reported through 2002 34

Distribution of Cumulative Adult/Adolescent AIDS Cases by Gender, Reported through June 2002
  WA USA
Men 9,436 680,909
Women 794 146,298
Total 10,230 827,208

 

New AIDS Cases

New AIDS Cases, Reported through 2002 477
New Adult/Adolescent AIDS Cases, Reported in 2001 532
New AIDS Cases in Children <13, Reported through December 2001 0

Distribution of New Adult/Adolescent AIDS Cases by Gender, Reported through June 2000
  WA USA
Men 472 31,901
Women 60 11,082
Total 532 42,983

 

Persons Living with AIDS

Estimated Number of Persons Living with AIDS at the End of 2002 4,889
Estimated Number of Adults/Adolescents Living with AIDS at the End of 2002 4,881
Estimated Number of Children Living with AIDS at the End of 2002 7
HIV Infection Cases Reported in 2002 Confidential

 

Total Deaths Reported through 2000, due to AIDS = 5,348
HIV Reporting Requirements ?   Yes, Name to Code Based.
 
HIV Testing Options?  Anonymous and Confidential testing
Definitions: Anonymous test: Individual does NOT use their name, and a name is not associated with test result. Anonymous tests are offered at anonymous testing centers, available in many, but not all, states.
Confidential test: Individual DOES use their name. If test is positive, individual's name will be known to their health care provider and, potentially, to other health care professionals and, in some cases, your state's Department of Health.
 
HIV Testing for Mothers and Newborns
Voluntary or Mandatory Testing?  Providers required to offer HIV test. Providers are required by law to offer HIV testing to pregnant women.
Voluntary HIV Testing: All states and the District of Columbia have certified to the CDC that they have measures in place to implement the CDC's 1995 recommendations on HIV counseling and testing of pregnant women.  The CDC's 1995 recommendations state that HIV testing of pregnant women and infants should be voluntary and providers must obtain informed consent for testing as required by their state laws.  Voluntary testing is noted if the state follows the CDC guidelines but does not have specific guidelines for testing of mothers and newborns.
 
Status of State Medicaid Expansion Efforts for People with HIV
Approved 1115 Waiver, TWWIIA demonstration? No, Has considered or is considering an 1115 Waiver to expand Medicaid eligibility to people with HIV.
Definitions: 1115 Waivers: Section 1115 of the Social Security Act authorizes the executive branch of the Federal government to waive the statutory and regulatory provisions of the Medicaid program. States have used "1115 waivers" to make changes in eligibility, benefits, and other areas of their Medicaid programs. The Centers for Medicare and Medicaid Services (CMS--formerly known as the Health Care Financing Administration) and several states have been analyzing the implications of expanding Medicaid eligibility to people with HIV prior to disability through the use of Section 1115 waivers of the Social Security Act. To use 1115 waivers, states face several challenges, particularly the need to demonstrate "budget neutrality" to the Medicaid program - that the costs of an expansion over a designated period of time (usually 5 years) would not exceed the costs to Medicaid in the absence of the expansion.
Ticket to Work/Work Incentives Improvement Act of 1999: TWWIIA expanded State options under Medicaid by creating new Medicaid buy-in options for working individuals with disabilities and extended Medicare cover-age for working individuals with disabilities. The Act also authorized state demonstration programs to provide Medicaid to workers with potentially severe disabilities, including HIV/AIDS, who are not yet disabled but whose health conditions could be expected to cause disability.
Notes: Most people with HIV who qualify for Medicaid do so by meeting the program’s income and disability standards once their illness has already progressed. Many low income people with HIV may be faced with of having their eligibility postponed until they become disabled, even though there are therapies available that may prevent disability and national treatment guidelines recommend access to early treatment. 1115 Waivers and TWWIIA demonstrations are two ways in which states have sought to address this limitation.

 
Sterile Syringe Exchange Programs?  Yes, The state Supreme Court has interpreted state law to allow health departments to conduct syringe exchange programs.
Notes: U.S. totals include data from the United States (50 states and the District of Columbia), and from U.S. dependencies, possessions, and independent nations in free association with the United States.
Definitions: Programs in operation: includes both state-sanctioned syringe exchange programs and non-sanctioned programs. Because their operation may not necessarily be authorized, it is difficult to account for an exact number of syringe exchange programs operation across the country; therefore, the list may not be comprehensive.
 
STD/HIV/AIDS Education Requirement?  Yes, Must stress abstinence and cover contraception.
 
Minors' Right to Consent to HIV/STD Services?  Yes. Minor must be at least 14 years of age. State explicitly classifies HIV/AIDS as an STD or infectious disease, for which minors may consent to testing and treatment.
 

 

 
Total Ryan White Funding, FY2000   $18,802,003 FY2002  $21,780,359

 

CDC HIV Prevention Funding for States
 FY2001 N/A

 FY2003   $3,908,673

 

Total Federal and State Funding for ADAP, FY2000  $7,866,199

Definitions: ADAPs: AIDS Drug Assistance Programs (ADAPs), authorized under Title II of the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act, provide HIV-related prescription drugs to underinsured and uninsured individuals living with HIV/AIDS. Each state or territory administers its own ADAP.

 

AIDS Drug Assistance Programs (ADAPs)
Source Kaiser Family Foundation

Total ADAP Clients Served, June 2002  
  WA
#		 US
#
   1,083 80,035

 
ADAP Clients Served by Sex, June 2002  
  WA
#		 WA
%		 US
#		 US
%
  Male 975 90 62,034 78
  Female 105 10 16,702 21
  Total 1,083 100 79,531 100

 
ADAP Clients Served by Race/Ethnicity, June 2002  
  WA
#		 WA
%		 US
#		 US
%
  White 699 65 29,426 37
  Black 112 10 26,245 33
  Hispanic 131 12 19,883 25
  Asian/Pacific Islander 22 2 795 1
  American Indian/Alaskan Native 15 1 795 1
  Other 103 10 795 1
  Total 1,083 100 79,531 100

 

ADAP Clients Served by Age, June 2002  
  WA
#		 WA
%		 US
#		 US
%
  <13 years old 1 0 795 1
  13-19 years old 0 0 0 1 0 1
  20-44 years old 677 62 50,105 63
  >44 years old 405 37 27,836 35
  Total 1,083 100 79,531 100

 
ADAP Clients Served by Income, June 2002  
  WA
#		 WA
%		 US
#		 US
%
  <100% FPL 392 36 38,175 48
  101-200% FPL 425 39 26,245 33
  201-300% FPL 197 18 8,748 11
  301-400% FPL 69 6 3,181 4
  >400% FPL 0 0 1,591 2
  Total 1,083 100 79,531 100

 
Insurance Coverage of ADAP Clients, June 2002  
  WA
#		 WA
%		 US
#		 US
%
  Medicaid 327 30 0 10
  Medicare 159 15 0 6
  Private 349 32 0 13

 
National ADAP Budget, Total Federal and State Sources, FY 2002  
  WA
$		 US
$
   9,509,184 878,610,754

 
National ADAP Budget by Source, FY 2002  
  WA
$		 WA
%		 US
$		 US
%
  ADAP Earmark 6,973,928 73 619,830,000 71
  Title II Base 325,776 3 28,886,192 3
  State 1,646,739 17 160,385,979 18
  Title I 562,741 6 19,736,619 2
  Other Federal 0 0 30,941,439 4
  ADAP Supplemental Grants 0 0 19,170,000 2
  Total 9,509,184 100 878,610,754 100

 
Total ADAP Drug Expenditures, June 2002  
  WA
$		 US
$
   672,366 70,705,142

 
ADAP Drug Expenditures by Drug Class, June 2002  
  WA
$		 WA
%		 US
$		 US
%
  Nucleoside Reverse Transcriptase Inhibitors 319,568 48 31,486,146 49
  non-Nucleoside Reverse Transcriptase Inhibitors 86,371 13 7,940,575 12
  Protease Inhibitors 148,734 22 16,433,502 25
  Opportunistic Infections/Other 117,694 18 9,015,329 14
  Total 672,366 100 64,875,793 100

 
Total ADAP Prescriptions Filled, June 2002  
  WA
#		 US
#
   4,587 257,279

 
ADAP Prescriptions Filled by Drug Class, June 2002  
  WA
#		 WA
%		 US
#		 US
%
  Nucleoside Reverse Transcriptase Inhibitors 1,501 33 83,166 36
  non-Nucleoside Reverse Transcriptase Inhibitors 443 10 23,933 10
  Protease Inhibitors 554 12 33,813 15
  Opportunistic Infections/Other 2,089 46 87,746 38
  Total 4,587 100 228,771 100

 
Federal ADAP Funds Used for Insurance Purchasing/Maintenance, FY 2002  
  WA
$		 US
$
   968,588 18,486,544

 
ADAP Formularies, Number of Medications by Drug Class, 2002  
  WA
#		 US
#
  Nucleoside Reverse Transcriptase Inhibitors 9 NA
  Protease Inhibitors Covered 6 NA
  Non-nucleosides Covered 3 NA
  OI Prophylaxis Covered 11 NA
  Other Medications Covered 108 NA
  Total 137 NA

 
ADAP Emergency Cost Containment Measures, February 2003  
  WA
 		 US
 
  Has ADAP Emergency Cost Containment Measures in Place Yes 16 Yes
  Notes Transferred funds to ADAP from other source; lowered financial eligibility criteria; reduced formulary.